← All bills

S. 355FDA Modernization Act 3.0

Progress: Passed / agreed in one chamberLatest action: Held at the desk.
119th CongressPolicy area: Health
  • John KennedyOriginal cosponsorFeb 3, 2025
Official CRS summary
Official CRS summary (Introduced in Senate version) · Congress.gov(opens in a new tab)

This bill requires the Food and Drug Administration (FDA) to publish an interim final rule implementing a provision of the Consolidated Appropriations Act of 2023 that authorized the use of certain alternatives to animal testing to support investigational use of a new drug.

The rule must replace references to animal tests, data, studies, models, and research with references to nonclinical tests, data, studies, models, and research throughout the FDA’s regulations governing investigational new drug applications, and may make other changes to the regulations as appropriate.

The rule must be published within one year of the bill’s enactment, and must take immediate effect as an interim final rule.

Introduced Feb 3, 2025
Latest action Dec 17, 2025Congress.gov(opens in a new tab)GovInfo action history(opens in a new tab)Status checked Nov 15, 2026Record permalink

Stable citation: ikhnae.com/bills/119/s/355

Report an error in this record →